We also talk about today’s DNA-related advances that use machine learning to design tailored Cas9 proteins, and multiple sequencing technologies to study mutation rates in four generations of the same ...

A team was able to edit the DNA of Lactobacillus strains directly without a template from other organisms. This technique is indistinguishable from natural variation and enabled the researchers to ...

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They include: ...

A Kobe University team was able to edit the DNA of Lactobacillus strains directly without a template from other organisms.

Crispr Therapeutics is an emerging gene editing company focused on the development of Crispr/Cas9-based therapeutics. The company's proprietary platform specializes in clustered regularly interspaced ...

A Kobe University team was able to edit the DNA of Lactobacillus strains directly without a template from other organisms.

Genome editing has advanced at a rapid pace with promising results for treating genetic conditions -- but there is always room for improvement. A new paper showcases the power of scalable protein ...

Learn about Brink Therapeutics as it raises $4 million to go beyond CRISPR with engineered recombinases in CAR T therapy.

The global gene therapy market is projected to grow at a significant CAGR of 20% from 2024 to 2029. This growth is driven by ...

A Vermont firm has recalled more than 1,700 pounds of butter because it may be contaminated with coliform, a type of bacteria found in fecal matter. Agri-Mark Inc., of Waitsfield, Vermont ...

The Type II CRISPR-Cas9 system, derived from Streptococcus pyogenes (SpCas9), was the first to be characterized and widely applied in genome editing. Cas9, guided by a single-guide RNA (sgRNA)—a ...